EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Evaluation of Novel (−) ‐cis‐N‐ Normetazocine Derivatives: In Vitro and Molecular Modeling Insights

Giuliana Costanzo iD, Alessandro Coco iD, Giuseppe Cosentino iD, Vincenzo Patamia iD, Carmela Parenti iD, Emanuele Amata iD, Agostino Marrazzo iD, Antonio Rescifina iD, Lorella Pasquinucci iD

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Giuliana Costanzo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug and Health Sciences, University of Catania, Catania, Italy. Hauptthemen laut MEDLINE: Drug Design, Receptors, Opioid, kappa, Receptors, Opioid, mu, Cyclazocine. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Catania, PIA.CE.RI. 2020-2022 Linea di intervento 2, project DETTAGLI (grant 57722172125), Università di Catania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Suitable structural modifications of the functional groups at N ‐substituent of (−)‐ cis ‐ N ‐normetazocine nucleus modulate the affinity and activity profile of related ligands toward opioid receptors. Our research group has developed several compounds and the most interesting ligands, LP1 and LP2 , exhibited a dual‐target profile for mu‐opioid receptor (MOR) and delta‐opioid receptor (DOR). Recent structure–affinity relationship studies led to the discovery of novel LP2 analogs (compounds 1 and 2 ), which demonstrated high MOR affinity in the nanomolar range. Here, we reported the synthesis of the new (−)‐ cis ‐ N ‐normetazocine derivatives ( 3 – 8 ) characterized by the absence of the phenyl ring in the N ‐substituent compared to all previous reported ligands. Compounds 3 and 4 , featuring a methyl ester functional group in the N ‐substituent, retained significant MOR affinity and exhibited similar affinity for the kappa‐opioid receptor (KOR). In contrast, compounds 7 and 8 , which contain a hydroxamic acid functionality, maintained affinity exclusively toward MOR. Neither of compounds ( 3 – 8 ) showed DOR affinity. Molecular modeling studies confirmed a similar docking pose in the MOR binding pocket for these compounds. Additionally, the in silico ADME profile of the most interesting ligands ( 3 , 4 , 7 , and 8 ) was investigated revealing a favorable profile for compound 7 regarding the blood–brain barrier permeability, suggesting its potential as a peripherally restricted opioid ligand.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignReceptors, Opioid, kappaReceptors, Opioid, muCyclazocineAnimalsHumansBinding SitesCHO CellsLigandsModels, MolecularMolecular Docking SimulationReceptors, Opioid, deltaStructure-Activity Relationship

Stichwörter der Autor:innen

ADME studiescis‐N‐normetazocinedocking studiesmu opioid receptorradioligand competition‐binding

Substanzen

LigandsReceptors, Opioid, deltaReceptors, Opioid, kappaReceptors, Opioid, munormetazocineCyclazocine

Autor:innen und Institutionen

  • Department of Drug and Health Sciences, University of Catania, Catania, Italy.

ORCID-Profile: Giuliana Costanzo, Alessandro Coco, Giuseppe Cosentino, Vincenzo Patamia, Carmela Parenti, Emanuele Amata, Agostino Marrazzo, Antonio Rescifina, Lorella Pasquinucci

Förderung

  • University of Catania, PIA.CE.RI. 2020-2022 Linea di intervento 2, project DETTAGLI (grant 57722172125)
  • Università di Catania

Zitieren

APA

Costanzo, G., Coco, A., Cosentino, G., Patamia, V., Parenti, C., Amata, E., Marrazzo, A., Rescifina, A., & Pasquinucci, L. (2024). Design, Synthesis, and Evaluation of Novel (−) ‐cis‐N‐ Normetazocine Derivatives: In Vitro and Molecular Modeling Insights. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70037

Vancouver

Costanzo G, Coco A, Cosentino G, Patamia V, Parenti C, Amata E, et al. Design, Synthesis, and Evaluation of Novel (−) ‐cis‐N‐ Normetazocine Derivatives: In Vitro and Molecular Modeling Insights. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.70037

BibTeX
@article{Costanzo2024,
  author = {Costanzo, Giuliana and Coco, Alessandro and Cosentino, Giuseppe and Patamia, Vincenzo and Parenti, Carmela and Amata, Emanuele and Marrazzo, Agostino and Rescifina, Antonio and Pasquinucci, Lorella},
  title = {Design, Synthesis, and Evaluation of Novel (−) ‐cis‐N‐ Normetazocine Derivatives: In Vitro and Molecular Modeling Insights},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.70037}
}
Kostenlos starten →